BioCentury | Feb 28, 2011
Company News

Univercell-Biosolutions S.A.S., Kyoto University deal

...failure rates in clinical trials. iPS is eligible for royalties. Further terms were not disclosed. Univercell-Biosolutions S.A.S....
Items per page:
1 - 1 of 1
BioCentury | Feb 28, 2011
Company News

Univercell-Biosolutions S.A.S., Kyoto University deal

...failure rates in clinical trials. iPS is eligible for royalties. Further terms were not disclosed. Univercell-Biosolutions S.A.S....
Items per page:
1 - 1 of 1